| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $255M | — | $212M | — | 20.4% |
| Op. Income | $84M | — | $65M | — | 29.4% |
| Gross Margin | 58.2% | — | 55.6% | — | 2.6pp |
| Net Margin | 24.1% | — | 21.5% | — | 2.6pp |
| EPS (Diluted) | $2.90 | — | $2.26 | — | 28.3% |
| Free Cash Flow | $71M | — | $51M | — | 39.6% |
| Item | Amount |
|---|---|
| REVENUE | $255M |
| Cost of Revenue | $107M |
| GROSS PROFIT | $149M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $41M |
| SG&A Expenses | $41M |
| Other Expenses | $24M |
| Operating Expenses | $65M |
| Cost & Expenses | $172M |
| OPERATING INCOME | $84M |
| Interest Income | $250M |
| Interest Expense | $97M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $84M |
| Income Tax Expense | $22M |
| Net Income from Continuing Ops | $62M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $62M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $62M |
| D&A | $3M |
| EBIT | $84M |
| EBITDA | $87M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $255M |
| Cost of Revenue | $107M |
| GROSS PROFIT | $149M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $41M |
| SG&A Expenses | $41M |
| Other Expenses | $24M |
| Operating Expenses | $65M |
| Cost & Expenses | $172M |
| OPERATING INCOME | $84M |
| Interest Income | $250M |
| Interest Expense | $97M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $84M |
| Income Tax Expense | $22M |
| Net Income from Continuing Ops | $62M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $62M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $62M |
| D&A | $3M |
| EBIT | $84M |
| EBITDA | $87M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $62M |
| Depreciation & Amortization | $3M |
| Stock-Based Compensation | $1M |
| Deferred Income Tax | -$578.0K |
| Other Non-Cash Items | $5M |
| Change in Working Capital | $2M |
| OPERATING CASH FLOW | $73M |
| Capital Expenditure | -$1M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $3.8B |
| Other Investing Activities | -$4.3B |
| NET CASH FROM INVESTING | -$544M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$17M |
| Other Financing Activities | $643M |
| NET CASH FROM FINANCING | $626M |
| FREE CASH FLOW | $71M |
| Net Change in Cash | $155M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $473M |
| Short-Term Investments | $95M |
| Net Receivables | $12M |
| Inventory | $0 |
| Other Current Assets | -$534M |
| TOTAL CURRENT ASSETS | $46M |
| PP&E (Net) | $13M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $4.1B |
| Tax Assets | $0 |
| Other Non-Current Assets | $614M |
| TOTAL NON-CURRENT ASSETS | $4.7B |
| TOTAL ASSETS | $4.8B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $2M |
| TOTAL CURRENT LIABILITIES | $2M |
| Long-Term Debt | $86M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $4.2B |
| TOTAL NON-CURRENT LIABILITIES | $4.3B |
| TOTAL LIABILITIES | $4.3B |
| Common Stock | $304M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $151M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$9M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $446M |
| Minority Interest | $0 |
| TOTAL EQUITY | $446M |
| TOTAL LIABILITIES & EQUITY | $4.8B |
| Total Debt | $98M |
| Net Debt | -$375M |
